Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
批准号:
10217189
负责人:
Robert William Huigens
金额:
$34.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2023-07-31
关键词:
AntibioticsAreaAwardBacteriaBacterial InfectionsBiologicalBiological PhenomenaBiological ProcessBiologyCancer BiologyCell SurvivalCellsCessation of lifeChemicalsChemistryComplexCritical PathwaysDiseaseEngineeringG-Protein-Coupled ReceptorsGoalsHealthHumanIn VitroIndole AlkaloidsInvestigationLeadLibrariesMicrobial BiofilmsNatural ProductsParentsPhenazinesPlasmodium falciparumProdrugsReactionSeriesSurfaceSystemTherapeutic AgentsUnited StatesYohimbinebacterial communitybasechemical synthesisdrug discoveryexperimental studyhuman diseaseinnovationinsightmethicillin resistant Staphylococcus aureusoxidationpersistent bacterial infectionpublic health relevancescaffoldsmall moleculetranscriptome sequencing
中文摘要
吲哚生物碱和吩嗪抗生素:药物发现的新平台
摘要:
新的小分子探针和治疗剂对于人类的研究和治疗至关重要
疾病。我们的小组正在开发多种化学合成策略来探测不同的生物
与人类疾病相关的现象,包括:细菌生物膜活力、GPCR 功能、癌症
生物学和恶性疟原虫生物学。我们开发了一种基于色氨酸的环失真
使用市售吲哚生物碱(育亨宾和长春胺)作为起点的策略
环畸变,或使用化学选择性对复杂环系统进行显着改变/重组
反应。这种方法能够快速合成高度复杂和多样化的支架
生物学研究,我们在多个疾病相关领域发现了热门化合物
关系到人类健康。我们的热门化合物已经获得了新的生物功能,因为它们的生物功能
活动与其他支架或其母体天然产物无关,本质上是对
吲哚生物碱的化学支架和生物学功能已被证明。此次颁奖期间,
我们将通过使用C-H氧化来增强我们的吲哚生物碱环畸变库的化学多样性
化学安装新的合成手柄,用于环畸变和非对映选择性氧化
重新排列以提供新的螺吲哚支架,最终目标是探索与疾病相关的
与我们的探针分子的化学空间。此外,我们小组还确定了一系列卤化物
吩嗪 (HP) 具有有效的生物膜根除活性。这些发现具有重要意义
细菌生物膜或表面附着的细菌群落,容纳持久的、非复制的细菌
(持久细胞)表现出对所有类别抗生素的耐受性。生物膜构成重大威胁
每年发生 1700 万例新的生物膜相关细菌感染,导致人类健康
美国有 55 万人死亡。我们的目标是使用我们开发的 HP 小分子
RNA-seq 实验中的探针分子与 MRSA 生物膜以及其他生物膜杀灭剂一起使用
研究生物膜的活力,目的是确定对生物膜至关重要的新靶点和细胞途径
细菌生物膜。此外,我们的目标是通过化学方法开发多种HP前药
合成和体外生物学研究。提供对生物膜至关重要的基础生物学的新见解
细胞活力和开发新的生物膜消除前药可能会带来突破性的治疗方法
持续的细菌感染。
Huigens (PI) 项目总结/摘要
英文摘要
Indole Alkaloids and Phenazine Antibiotics: New Platforms For Drug Discovery
Abstract:
New small molecule probes and therapeutic agents are critical for the study and treatment of human
disease. Our group is developing multiple chemical synthesis strategies to probe diverse biological
phenomena related to human disease, including: bacterial biofilm viability, GPCR function, cancer
biology and Plasmodium falciparum biology. We have developed a tryptoline-based ring distortion
strategy using commercially available indole alkaloids (yohimbine and vincamine) as starting points for
ring distortion, or the dramatic altering/reorganization of complex ring systems using chemoselective
reactions. This approach has enabled the rapid synthesis of highly complex and diverse scaffolds for
biological investigations and we have identified hit compounds in multiple disease-relevant areas
pertinent to human health. Our hit compounds have gained new biological functions as their biological
activities are unrelated to other scaffolds or their parent natural product, in essence, re-engineering of
indole alkaloid’s chemical scaffolds and biological functions have been demonstrated. During this award,
we will enhance the chemical diversity of our indole alkaloid ring distortion library by using C-H oxidation
chemistry to install new synthetic handles for ring distortion and diastereoselective oxidative
rearrangements to give new spirooxindole scaffolds with the ultimate goal of exploring disease-relevant
chemical space with our probe molecules. In addition, our group has identified a series of halogenated
phenazines (HP) that demonstrate potent biofilm-eradicating activities. These findings are significant as
bacterial biofilms, or surface-attached bacterial communities, house persistent, non-replicating bacteria
(persister cells) that demonstrate tolerance to all classes of antibiotics. Biofilms pose a significant threat
to human health as 17 million new biofilm-associated bacterial infections occur annually that result in
550,000 deaths in the United States. We aim to use the HP small molecules we have developed as
probe molecules in RNA-seq experiments with MRSA biofilms alongside other biofilm-killing agents to
investigate biofilm viability with the goal of identifying new targets and cellular pathways critical to
bacterial biofilms. In addition, we aim to develop a diverse array of HP prodrugs through chemical
synthesis and in vitro biological studies. Providing new insights into the basic biology critical to biofilm
cell viability and developing new biofilm-eradicating prodrugs could lead to ground-breaking cures for
persistent bacterial infections.
Huigens (PI) Project Summary/Abstract
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
-
批准号:10377920
-
项目类别:
-
资助金额:$19.01万
-
财政年份:2021
-
负责人:Robert William Huigens
-
依托单位:
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
-
批准号:10193679
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2021
-
负责人:Robert William Huigens
-
依托单位:
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
-
批准号:9983101
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2018
-
负责人:Robert William Huigens
-
依托单位:
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
-
批准号:10451729
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2018
-
负责人:Robert William Huigens
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: